This company has been marked as potentially delisted and may not be actively trading. Timber Pharmaceuticals (TMBR) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock TMBR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period MSG Networks in talks to avoid bankruptcy — possibly with help of Amazon: sourcesJanuary 31, 2025 | nypost.comNTimber back in Dutch squad and twin brother also called upAugust 30, 2024 | reuters.comCan timber construction overcome its growing pains?May 13, 2024 | reuters.comTimber Pharmaceuticals, Inc., a LEO Pharma Company, Presents Late-Breaking Preliminary Results of TMB-001 in Moderate-to-Severe Congenital Ichthyosis (CI) at the 2024 AAD Annual MeetingMarch 10, 2024 | businesswire.comTimber Pharmaceuticals Announces Official Name ChangeJanuary 28, 2024 | msn.comTimber Pharmaceuticals Inc (TMBRQ)January 13, 2024 | uk.investing.comTimber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC MarketNovember 29, 2023 | finance.yahoo.comNYSE American to Suspend Trading Immediately in Timber Pharmaceuticals, Inc. (TMBR)November 29, 2023 | finance.yahoo.comTimber Pharmaceuticals Receives Court Approval of All "First Day" Motions to Support Business Operations & Discloses Communication From NYSE AmericanNovember 28, 2023 | tmcnet.comTimber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE AmericanNovember 28, 2023 | finance.yahoo.comMVST, FBIO and VTVT among mid-day moversNovember 21, 2023 | seekingalpha.comTimber Pharmaceuticals files for Chapter 11 in wake of failed mergerNovember 17, 2023 | msn.comTimber Pharma slips ahead of shareholder vote on mergerNovember 16, 2023 | msn.comTimber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing ComplianceSeptember 18, 2023 | finance.yahoo.comHC Wainwright Downgrades Timber PharmaceuticalsAugust 29, 2023 | 247wallst.comHC Wainwright & Co. Downgrades Timber Pharmaceuticals (TMBR)August 28, 2023 | msn.comTMBR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Timber Pharmaceuticals, Inc. Is Fair to ShareholdersAugust 21, 2023 | benzinga.comDow Tumbles Over 100 Points; Timber Pharmaceuticals Shares Spike HigherAugust 21, 2023 | markets.businessinsider.comTimber to be taken private by LEO Pharma, stock soars 100%August 21, 2023 | msn.comWhy Is Timber Pharmaceuticals (TMBR) Stock Up 96% Today?August 21, 2023 | investorplace.comUS Stocks Mostly Higher; Nasdaq Jumps 100 PointsAugust 21, 2023 | markets.businessinsider.comTimber Pharmaceuticals Shares Soar on Takeover by LEO PharmaAugust 21, 2023 | marketwatch.comWhy Timber Pharmaceuticals Stock Is Skyrocketing TodayAugust 21, 2023 | benzinga.comLEO Pharma Signs Agreement to Acquire Timber PharmaceuticalsAugust 21, 2023 | finance.yahoo.comTimber Pharmaceuticals to be Acquired by LEO PharmaAugust 21, 2023 | finance.yahoo.comTimber Pharmaceuticals Inc Ordinary SharesAugust 15, 2023 | morningstar.comMTimber Pharmaceuticals Discloses Communication From NYSE AmericanJuly 3, 2023 | finance.yahoo.comTimber Pharmaceuticals Soars as FDA Removes HurdleJune 5, 2023 | msn.comTimber Pharmaceuticals stock jumps as much as 83% after FDA waiver to forgo rodent studyJune 5, 2023 | msn.comTimber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001June 5, 2023 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial ResultsMay 15, 2023 | finance.yahoo.comBears are Losing Control Over Timber Pharmaceuticals, Inc. (TMBR), Here's Why It's a 'Buy' NowApril 14, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates Timber Pharmaceuticals (TMBR) Buy RecommendationApril 11, 2023 | msn.comTimber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial ResultsMarch 31, 2023 | finance.yahoo.comTimber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental DermatologyMarch 20, 2023 | finance.yahoo.comTimber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive IchthyosisFebruary 24, 2023 | finance.yahoo.comWhy Is Timber Pharmaceuticals (TMBR) Stock Up 61% Today?February 24, 2023 | investorplace.comTimber Pharmaceuticals, Inc. (TMBR)February 20, 2023 | uk.finance.yahoo.comTimber Pharmaceuticals to Host Investor Business Briefing: Milestone Achievements and Forward OutlookDecember 14, 2022 | finance.yahoo.comTimber Pharmaceuticals Regains Compliance with NYSE American Continued Listing StandardsDecember 9, 2022 | finance.yahoo.comTimber Pharmaceuticals Provides Business Update and Announces Third Quarter 2022 Financial ResultsNovember 14, 2022 | finance.yahoo.comWhy RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day SessionNovember 9, 2022 | msn.comTimber Pharmaceuticals, Inc. Announces 1-for-50 Reverse Stock SplitNovember 8, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces Halt of Common Stock TradingNovember 3, 2022 | finance.yahoo.comTimber Pharmaceuticals Receives European Orphan Designation for Autosomal Recessive Congenital Ichthyosis & Positive Comments on Pediatric Investigation Plan for TMB-001 in Autosomal Recessive CI & X-Linked Recessive IchthyosisOctober 25, 2022 | finance.yahoo.com1TMBR : Why Timber Pharmaceuticals Shares Are Getting HammeredOctober 3, 2022 | msn.comTimber Pharmaceuticals Announces $1.3 Million Registered Direct OfferingOctober 3, 2022 | finance.yahoo.comTimber Pharmaceuticals Receives Positive Opinion on Orphan Designation from European Medicines Agency for TMB-001 for Treatment of Autosomal Recessive Congenital IchthyosisSeptember 14, 2022 | finance.yahoo.comTimber Pharmaceuticals Announces Notification of NYSE American Continued Listing DeficiencyAugust 29, 2022 | finance.yahoo.comTimber Pharmaceuticals to Highlight Phase 2b CONTROL Study Results in Multiple Presentations at 31st EADV CongressAugust 29, 2022 | finance.yahoo.com Get Timber Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TMBR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TMBR Media Mentions By Week TMBR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TMBR News Sentiment▼0.000.94▲Average Medical News Sentiment TMBR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TMBR Articles This Week▼00▲TMBR Articles Average Week Get the Latest News and Ratings for TMBR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Timber Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies China Pharma News Today Spruce Biosciences News Today Oragenics News Today Orgenesis News Today Can-Fite BioPharma News Today Universe Pharmaceuticals News Today Avenue Therapeutics News Today Vaccinex News Today Evofem Biosciences News Today Bio-Path News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:TMBR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis Coin Could Explode, and it’s Hiding in Plain Sight!The #1 coin with skyrocket potential right now... Sometimes the biggest opportunities are hiding in plain s...Crypto 101 Media | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored“Godfather of AI’s” dire warningAI pioneer Geoffrey Hinton warns the technology could create massive unemployment and widen inequality, but Po...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Timber Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Timber Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TMBR Stock Alerts